White Marvin L has filed 19 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 30000 shares of Aptevo Therapeutics Inc. ($APVO) on August 06, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 6, 2025 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | A | Restricted Stock Unit | 30000 | $0.00 | 30,000.0000 | 1,458,445 | 9999.99% | 2.06% |
| July 17, 2025 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | M | Restricted Stock Unit | 10 | $0.00 | 20.0000 | 1,458,445 | 33.33% | 0.00% |
| July 17, 2025 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | M | Common Stock | 10 | $0.00 | 12.0000 | 1,458,445 | 500.00% | 0.00% |
| April 30, 2025 | Emergent BioSolutions Inc. | $EBS | White Marvin L | Director | A | Stock Option (Right to Buy) | 15824 | $0.00 | 41,572.0000 | 53,000,000 | 61.46% | 0.03% |
| April 30, 2025 | Emergent BioSolutions Inc. | $EBS | White Marvin L | Director | A | Common Stock | 34403 | $0.00 | 88,495.0000 | 53,000,000 | 63.60% | 0.06% |
| March 3, 2025 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | M | Common Stock | 6 | $0.00 | 55.0000 | 1,458,445 | 12.24% | 0.00% |
| March 2, 2025 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | M | Common Stock | 8 | $0.00 | 49.0000 | 1,458,445 | 19.51% | 0.00% |
| March 2, 2025 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | M | Restricted Stock Unit | 8 | $0.00 | 8.0000 | 1,458,445 | 50.00% | 0.00% |
| March 3, 2025 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | M | Restricted Stock Unit | 6 | $0.00 | 0.0000 | 1,458,445 | 100.00% | 0.00% |
| Nov. 11, 2024 | Emergent BioSolutions Inc. | $EBS | White Marvin L | Director | S | Common Stock | 14287 | $11.97 | 54,092.0000 | 55,600,000 | 20.89% | 0.03% |
| July 17, 2024 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | A | Restricted Stock Unit | 22325 | $0.00 | 22,325.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2024 | Emergent BioSolutions Inc. | $EBS | White Marvin L | Director | A | Common Stock | 17430 | $0.00 | 68,379.0000 | 51,200,000 | 34.21% | 0.03% |
| May 23, 2024 | Emergent BioSolutions Inc. | $EBS | White Marvin L | Director | A | Stock Option (Right to Buy) | 25748 | $0.00 | 25,748.0000 | 51,200,000 | 9999.99% | 0.05% |
| March 3, 2024 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | M | Restricted Stock Unit | 9584 | $0.00 | 9,584.0000 | 0 | 50.00% | 0.00% |
| March 2, 2024 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | M | Common Stock | 12917 | $0.00 | 57,846.0000 | 0 | 28.75% | 0.00% |
| March 3, 2024 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | M | Common Stock | 9584 | $0.00 | 67,430.0000 | 0 | 16.57% | 0.00% |
| March 2, 2024 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | M | Restricted Stock Unit | 12917 | $0.00 | 25,833.0000 | 0 | 33.33% | 0.00% |
| Jan. 28, 2024 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | M | Restricted Stock Unit | 4792 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 28, 2024 | Aptevo Therapeutics Inc. | $APVO | White Marvin L | President and CEO | M | Common Stock | 4792 | $0.00 | 44,929.0000 | 0 | 11.94% | 0.00% |